Orange Book product · Brand (NDA)
LINCOCIN
LINCOMYCIN HYDROCHLORIDE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
AP
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
LINCOMYCIN HYDROCHLORIDE
Strength
EQ 300MG BASE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
NDA 050317
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- —LINCOCINBrand (NDA)
NDA 050316 · PHARMACIA AND UPJOHN
- 2022LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 216662 · SLATE RUN PHARMA
- 2022LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215657 · GLAND
- 2021LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 215082 · MICRO LABS
- 2021LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 212770 · ARTHUR GRP
- 2015LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 201746 · XGEN PHARMS
- 1991LINCOMYCIN HYDROCHLORIDEGeneric (ANDA)
ANDA 063180 · SLAYBACK
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
